Prevalence estimates of recurrent balanced cytogenetic aberrations and gene fusions in unselected patients with neoplastic disorders

Genes Chromosomes and Cancer

Volumn 43, Issue 4, 2005, Pages 350-366

  Mitelman, Felix ^a   Mertens, Fredrik ^a   Johansson, Bertil ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHROMOSOME ABERRATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CYTOGENETICS; DISEASE ASSOCIATION; EPITHELIUM TUMOR; GENE FUSION; GERM CELL TUMOR; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; LEUKEMIA; LYMPHOMA; MELANOCYTOSIS; MOLECULAR GENETICS; MYELOPROLIFERATIVE DISORDER; NEOPLASM; PLASMA CELL DYSCRASIA; PREVALENCE; PRIORITY JOURNAL; SOLID TUMOR;

ARTIFICIAL GENE FUSION; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATIONS; GENE REARRANGEMENT; HUMANS; NEOPLASMS;

EID: 21744437101     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20212     Document Type: Article

References (38)

1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton, DA, Gralnick HR, Sultan C. 1976. Proposals for the classification of the acute leukaemias. French-American-British Cooperative Group. Br J Haematol 33:451-458.
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton, DA, Gralnick HR, Sultan C. 1982. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189-199.
3. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton, DA, Gralnick HR, Sultan C. 1985. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-Bricish Cooperative Group. Ann Intern Med 103:620-625.
4. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick H, Sultan C, Cox C. 1994. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocycic, atypical chronic myeloid, and chronic myelomonocycic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group. Br J Haematol 87:746-754.
5. Bergsagel PL, Chesi M, Nardini E, Brents LA, Kirby SL, Kuehl WM. 1996. Promiscuous cranslocations into immunoglobulin heavy chain switch regions in multiple myeloma. Proc Natl Acad Sci USA 93:13931-13936.
6. Chessells JM, Harrison CJ, Kempski H, Webb DKH, Wheatley K, Hann IM, Stevens RF, Harrison G, Gibson BE. 2002. Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party. Leukemia 16:776-784.
7. Darnell JE. 2002. Transcription factors as targets for cancer therapy. Nat Rev Cancer 2:740-749.
8. Druker BJ. 2003. Imatinib as a paradigm of targeted therapies. J Clin Oncol 23:239-245.
9. Fletcher CDM, Unni KK, Mertens F, editors. 2002. World Health Organization classification of tumours. Tumours of soft tissue and bone. Lyon, France: IARC Press.
10. Fröhling S, Skelin S, Liebisch C, Scholl C, Schlenk RF, Döhner H, Döhner K. 2002. Comparison of cytogenetic and molecular cytogenetic detection of chromosome abnormalities in 240 consecutive adult patients with acute myeloid leukemia. J Clin Oncol 20:2480-2485.
11. Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Bray-Ward P, Morgan E, Raimondi SC, Rowley JD, Gilliland DG. 1995. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA 92:4917-4921.
12. Gorunova L, Höglund M, Andrén-Sandberg Å, Dawiskiba S, Jin Y, Mitelman F, Johansson B. 1998. Cytogenetic analysis of pancreatic carcinomas: intratumor heterogeneity and nonrandom pattern of chromosome aberrations. Genes Chromosomes Cancer 23:81-99.
13. Grimwade D, Walker H, Harrison G, Oliver F, Chatters S, Harrison CJ, Wheatley K, Burnett AK, Goldstone AH. 2001. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 98:1312-1320.
14. Heim S, Mandahl N, Mitelman F. 1988. Genetic convergence and divergence in tumor progression. Cancer Res 48:5911-5916.
15. Helman LJ, Meltzer P. 2003. Mechanisms of sarcoma development. Nat Rev Cancer 3:685-694.
16. Hokland P, Pallisgaard N. 2000. Integration of molecular methods for detection of balanced translocations in the diagnosis and follow-up of patients with leukemia. Semin Hematol 37:358-367.
17. ICD-O. 1990. International classification of diseases for oncology. Geneva, Switzerland: WHO.
18. Jaffe ES, Lee Harris N, Stein H, Vardiman JW, editors. 2001. World Health Organization classification of tumours. Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press.
19. Johansson B, Mertens F, Mitelman F. 1991. Geographic heterogeneity of neoplasia-associated chromosome aberrations. Genes Chromosomes Cancer 3:1-7.
20. Look AT. 1997. Oncogenic transcription factors in human acute leukemias. Science 278:1059-1064.
21. Mandahl N, Höglund M, Mertens F, Rydholm A, Willén H, Brosjö O, Mitelman F. 1994. Cytogenetic aberrations in 188 benign and borderline adipose tissue tumors. Genes Chromosomes Cancer 9:207-215.
22. Mitelman F, Johansson B, Mertens F. editors. 2004a. Mitelman Database of Chromosome Aberrations in Cancer. Available at: http://cgap.nci.nih.gov/ Chromosomes/Mitelman.
23. Mitelman F, Johansson B, Mertens F. 2004b. Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer. Nat Genet 36:331-334.
24. Panagopoulps I, Mertens F, Isaksson M, Limon J, Gustafson P, Skytting B, Åkerman M, Sciot R, Dal Cin P, Samson I, Iliszko M, Ryoe J, Dêbiec-Rychter M, Szadowska A, Brosjö O, Larsson O, Rydholm A, Mandahl N. 2001. Clinical impact of molecular and cytogenetic findings in synovial sarcoma. Genes Chromosomes Cancer 31:362-372.
25. Rabbitts TH. 1994. Chromosomal translocations in human cancer. Nature 372:143-149.
26. Rabbitts TH, Stocks MR. 2003. Chromosomal translocation products engender new intracellular therapeutic technologies. Nat Med 9:383-386.
27. Raimondi SC, Chang MN, Ravindranath Y, Behm FG, Gresik MV, Steuber CP, Weinstein HJ, Carroll AJ. 1999. Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative Pediatric Oncology Group study-POG 8821. Blood 94:3707-3716.
28. Romana SP, Mauchauffe M, Le Coniat M, Chumakov I, Le Paslier D, Berger R, Bernard OA. 1995. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 85:3662-3670.
29. Rowley JD. 2001. Chromosomal translocations: dangerous liaisons revisited. Nat Rev Cancer 1:245-250.
30. Sako-Tellez M, Shelat SG, Benoit B, Rennert H, Carroll M, Leonard DG, Nowell P, Bagg A. 2003. Multiplex RT-PCR for the detection of leukemia-associated translocations: validation and application to routine molecular diagnostic practice. J Mol Diagn 4:231-236.
31. Santoro M, Dathan NA, Berlingieri MT, Bongarzone I, Paulin C, Grieco M, Pierotti MA, Vecchio G, Fusco A. 1994. Molecular characterization of RET/PTC3; a novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma. Oncogene 9:509-516.
32. Schoch C, Schnittger S, Kern W, Dugas M, Hiddemann W, Haferlach T. 2003. Acute myeloid leukemia with recurring chromosome abnormalities as defined by the WHO-classification: incidence of subgroups, additional genetic abnormalities, FAB subtypes and age distribution in an unselected series of 1,897 patients with acute myeloid leukemia. Haematologica 88:351-352.
33. Shi RZ, Morrissey JM, Rowley JD. 2003. Screening and quantification of multiple chromosome translocations in human leukemia. Clin Chem 49:1066-1073.
34. So CW, Caldas C, Liu M-M, Chen S-J, Huang Q-H, Gu L-J, Sham MH, Wiedemann LM, Chan LC. 1997. EEN encodes for a member of a new family of proteins containing an Src homology 3 domain and is the third gene located on chromosome 19p13 that fuses to MLL in human leukemia. Proc Natl Acad Sci USA 94:2563-2568.
35. Swolin B, Weinfeld A, Westin J. 1988. A prospective long-term cytogenetic study in polycythemia vera in relation to treatment and clinical course. Blood 72:386-395.
36. van der Burg M, Poulsen TS, Hunger SP, Beverloo HB, Smit EME, Vang-Nielsen K, Langerak AW, van Dongen JJM. 2004. Split-signal FISH for detection of chromosome aberrations in acute lymphoblastic leukemia. Leukemia 18:895-908.
37. Yamamoto K, Seto M, Komatsu H, Iida S, Akao Y, Kojima S, Kodera Y, Nakazawa S, Ariyoshi Y, Takahashi T, Ueda R. 1993. Two distinct portions of LTG19/ENL at 19p13 are involved in t(11;19) leukemia. Oncogene 8:2617-2625.
38. Yuki Y, Imoto I, Imaizumi M, Hibi S, Kaneko Y, Amagasa T, Inazawa J. 2004. Identification of a novel fusion gene in a pre-B acute lymphoblastic leukemia with t(1;19)(q23:p13). Cancer Sci 95:503-507.